Renown Regional Medical Center is part of Renown Health, a non-profit hospital in Reno, Nevada. It is Renown Health's flagship hospital and the region's only level II trauma center. Renown Regional facilitates the area's only dedicated children's hospital, Renown Children's Hospital. The hospital was founded in 1876.

There are 650 beds in Renown Regional Medical Center.

During the past decade, Renown Regional Medical Center conducted 192 clinical trials. In the 10-year time frame, 192 clinical trials started and 83 clinical trials were completed, i.e. on average, 43.2% percent of trials that started reached the finish line to date. In the past 5 years, 73 clinical trials started and 60 clinical trials were completed. i.e. 82.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Renown Regional Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 107 trials, followed by "SWOG Cancer Research Network" with 32 trials sponsored, "Alliance for Clinical Trials in Oncology" with 26 trials sponsored, "Children's Oncology Group" with 22 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 22 trials sponsored. Other sponsors include 55 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Renown Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 124 trials as a collaborator, "NRG Oncology" with 30 trials as a collaborator, "Canadian Cancer Trials Group" with 11 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator and "Radiation Therapy Oncology Group" with 6 trials as a collaborator. Other collaborators include 46 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Renown Regional Medical Center" are "Invasive Breast Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Recurrent Ovarian Carcinoma" (8 trials), "Stage IV Lung Cancer AJCC v8" (8 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Renown Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Renown Regional Medical Center" are "Drug" (199 trials), "Other" (148 trials), "Biological" (93 trials), "Procedure" (75 trials) and "Radiation" (64 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (70 trials), "Quality-of-Life Assessment" (62 trials), "Questionnaire Administration" (42 trials), "Biospecimen Collection" (38 trials) and "Computed Tomography" (38 trials). Other intervention names were less common.

The vast majority of trials in "Renown Regional Medical Center" are 209 trials for "All" genders, 42 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Renown Regional Medical Center". undefined are not yet recruiting, 78 are recruiting, 111 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Renown Regional Medical Center, 8 suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Renown Regional Medical Center, 3 "Phase 1" clinical trials were conducted, 109 "Phase 2" clinical trials and 145 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 10 trials that are defined as “Not Applicable".

Renown Regional Medical Center has several departments that took part in Clinical trials: "Renown Institute for Cancer at Renown Regional Medical Center" - 17 trials, "Renown Institute for Heart and Vascular Health" - 5 trials, "Renown Institute for Neurosciences" - 5 trials